Skip to main contentSkip to navigation
Sirius Investors

PODD Stock: Insulet Corporation Stock Price, Analysis & Insights

Get live podd stock price $326.80, comprehensive Insulet Corporation stock analysis, charts, news, and expert forecast. Real-time podd stock data and investment insights.

326.80
0.62%Today
PODDInsulet Corporation • NASDAQ Global Select • Healthcare
Market Cap
22.99B
Volume
641.63K
52W High
354.88
52W Low
230.05

Loading chart...

Company Overview

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Company Information

CEO
Ashley A. McEvoy
Sector
Healthcare
Industry
Medical - Devices
Employees
3900

Contact Information

Address
100 Nagog Park
Country
US

Investment Analysis & Business Insights

Healthcare
Medical - Devices

Investment Highlights

Strong presence in the Healthcare sector with established market position

Growth-oriented company with premium valuation (P/E: 95.0)

Higher growth potential with elevated volatility (Beta: 1.38)

Business Model & Strategy

Insulet Corporation operates in the Medical - Devices industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Ashley A. McEvoy, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Devices model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.

Market Position & Competitive Landscape

Insulet Corporation competes in the Medical - Devices within the broader Healthcare. With 23.0 billion in market capitalization, the company is positioned as a established player in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Global Select, Insulet Corporation provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Insulet Corporation should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Insulet Corporation shareholders
  • Market volatility can significantly impact stock price, especially for mid-cap stocks
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Insulet Corporation
  • Investors should consider how Insulet Corporation fits within their overall portfolio allocation
  • Premium valuation (P/E: 95.0) requires strong growth to justify

Market Cap

22.99B

P/E Ratio

95.00

Beta

1.38

Investment Analysis & Insights

Key Investment Highlights

  • Market Position: Healthcare leader with 22.99B market capitalization
  • Trading Volume: 641.63K shares traded today
  • Price Range: 52-week range of $230.05 - $354.88
  • Exchange: Listed on NASDAQ Global Select

Financial Metrics

P/E Ratio:95.00
EPS:$3.44
Beta:1.38
Avg Volume:638.18K

Market Analysis for Insulet Corporation

Insulet Corporation (PODD) operates in the Medical - Devices industry within the Healthcare sector. With a current market capitalization of 22.99B, the company represents a significant player in its market. The stock is currently trading at $326.80 with a negativedaily change of 0.62%.

The company's 3900 employee base and presence on the NASDAQ Global Selectexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 95.00, beta of 1.38, and 52-week price range from $230.05 to $354.88when evaluating investment opportunities.

Why Invest in Insulet Corporation?

Strengths
  • • Established market presence in Healthcare
  • • Strong financial metrics and market position
  • • Listed on major exchange (NASDAQ Global Select)
  • • Experienced leadership under Ashley A. McEvoy
Investment Considerations
  • • Monitor sector-specific market trends
  • • Track quarterly earnings performance
  • • Consider market volatility and beta
  • • Evaluate long-term growth potential

Related Healthcare Stocks

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.